VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
VM Oncology, LLC
Memorial Sloan Kettering Cancer Center
7 Hills Pharma, LLC
Incyte Corporation
NuCana plc
Deciphera Pharmaceuticals, LLC
Institut Bergonié
National Institutes of Health Clinical Center (CC)